Ingersoll Rand (IR) reported $1.96 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 5.1%. EPS of $0.86 for the same period compares to $0.84 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $1.95 billion, representing a surprise of +0.39%. The company has not delivered EPS surprise, with the consensus EPS estimate being $0.86.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Ingersoll performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:- Revenue- Precision and Science Technologies: $414.5 million versus $411.42 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +5.3% change.
- Revenue- Industrial Technologies and Services: $1.54 billion versus the three-analyst average estimate of $1.53 billion. The reported number represents a year-over-year change of +5%.
- Adjusted EBITDA- Precision & Science Technologies: $127.6 million versus the three-analyst average estimate of $125.52 million.
- Adjusted EBITDA- Industrial Technologies & Services: $447.5 million versus the three-analyst average estimate of $452.81 million.
View all Key Company Metrics for Ingersoll here>>>
Shares of Ingersoll have returned -4.6% over the past month versus the Zacks S&P 500 composite's +3.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"
Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.
See Our Top Stock to Double (Plus 4 Runners Up) >>Ingersoll Rand Inc. (IR) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
